Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Antithrombin III (human)
Trade Name: ATnativ
Date Designated: 02/08/1985
Orphan Designation: For the treatment of patients with hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism.
Orphan Designation Status: Designated/Approved
Pharmacia & Upjohn AB
Lindhagensgatan 133
Stockholm
Sweden

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Antithrombin III (human)
Trade Name: ATnativ
Marketing Approval Date: 12/13/1989
Approved Labeled Indication:
Exclusivity End Date: 12/13/1996 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-